Müller F

Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis.

Florineth GA, Boeker AL, Bracht T +5

PreprintPsilocybin

Psychedelics Restructure the Global Workspace of Consciousness

Yousefi P, Shinozuka K, Vizeli P +8

Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.

Jaeckel LF, Logvinski D, Kanana M +5

LSD therapy: A few hundred meters from where it began.

Müller F, Becker AM, Böhlke C +2

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

Avram M, Menegaux A, Müller F +7

Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.

Florineth GA, Klima I, Boeker AL +8

Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.

Holze F, Liechti ME, Müller F

Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial.

Müller F, Zaczek H, Becker AM +8

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Mueller L, Santos de Jesus J, Schmid Y +9

Further education in psychedelic-assisted therapy - experiences from Switzerland.

Aicher HD, Müller F, Gasser P

Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.

Müller F, Sauer T, Hänny C +2

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.

Avram M, Fortea L, Wollner L +10

Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.

Vizeli P, Studerus E, Holze F +8

Europe PMC2024

LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.

Holze F, Gasser P, Müller F +2

Europe PMC2024

Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration.

Avram M, Müller F, Preller KH +8

Europe PMC2024

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.

Bedford P, Hauke DJ, Wang Z +9

Europe PMC2023

PreprintLSD

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Bedford P, Hauke DJ, Wang Z +9

Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Holze F, Gasser P, Müller F +2

Europe PMC2023

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

McCulloch DE, Knudsen GM, Barrett FS +10

Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration.

Avram M, Müller F, Rogg H +7

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

Holze F, Ley L, Müller F +10

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

Müller F, Kraus E, Holze F +6

ArticlePsychedelics

Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States.

Avram M, Rogg H, Korda A +3

PreprintPsilocybin

Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses

McCulloch DE, Knudsen GM, Barrett FS +9

Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Mason NL, Kuypers KPC, Reckweg JT +7

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.

Müller F, Holze F, Dolder P +5

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects.

Müller F, Mühlhauser M, Holze F +4

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.

Holze F, Vizeli P, Ley L +8

Editorial: Hallucinogens and Entactogens: Establishing a New Class of <i>Psychotherapeutic</i> Drugs?

Müller F, Johnson MW, Borgwardt S

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

Mason NL, Kuypers KPC, Müller F +8

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.

Holze F, Vizeli P, Müller F +6

Acute effects of lysergic acid diethylamide (LSD) on resting brain function.

Müller F, Borgwardt S

Europe PMC2019

Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.

Müller F, Liechti ME, Lang UE +1

Europe PMC2018

Altered network hub connectivity after acute LSD administration.

Müller F, Dolder PC, Schmidt A +2

Europe PMC2018

Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.

Müller F, Lenz C, Dolder P +4

Europe PMC2017